首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >Significance of notch1-signaling pathway in human pancreatic development and carcinogenesis
【24h】

Significance of notch1-signaling pathway in human pancreatic development and carcinogenesis

机译:Notch1信号通路在人胰腺发育和致癌中的意义

获取原文
获取原文并翻译 | 示例
           

摘要

In animal studies, Notch1-signaling pathway plays an important role in the pancreatic embryogenesis by promoting pancreatic progenitor cells self-renewal and exocrine linage development. The persistent activation of Notch pathway could arrest the organ development and keep cells at an undifferentiated stage. Studies have shown that Notch1-signaling pathway is upregulated in invasive pancreatic ductal adenocarcinoma (PDAC). Here we examined the expression pattern of Notch1 and Hes1 in human fetal pancreatic tissues to elucidate the role of Notch1 in human pancreatic embryonic development. We also compared Notch1 expression in tissues from PDAC, chronic pancreatitis and pancreatic intraepithelial neoplasm. Our data show that Notch1/Hes1-signaling pathway is activated during early pancreatic embryogenesis and reaches the highest at birth. After pancreas is fully developed, Notch1/Hes1 pathway is inactivated even though Notch1 protein cell-surface expression is upregulated. We also showed that the expression of both Notch1 and Hes1 are present in 50% (33/66) of PDACs, but not in pancreatic intraepithelial neoplasms. These findings indicate that Notch1 activation is only apparent in late stage of pancreatic carcinogenesis, suggesting that treatment with Notch-signaling inhibitors including γ-secretase should be selectively used for PDACs with confirmed Notch1-signaling activation.
机译:在动物研究中,Notch1-Signaling途径通过促进胰腺祖细胞自我更新和外泌术脉冲型发育来发挥胰腺胚胎发生中的重要作用。凹口途径的持续激活可以抑制器官发展,并使细胞保持在未分化的阶段。研究表明,在侵袭性胰腺导管腺癌(PDAC)中令人兴奋地上调Notch1信号通路。在这里,我们检查了人类胎儿胰腺组织中Notch1和Hes1的表达模式,以阐明Notch1在人胰腺胚胎发育中的作用。我们还比较了来自PDAC,慢性胰腺炎和胰腺上皮内肿瘤组织中的Notch1表达。我们的数据表明,在早期胰腺胚胎发生期间激活Notch1 / Hes1-信号通路,达到出生时最高。在完全开发胰腺后,即使没有上调Notch1蛋白质细胞表面表达,尚未激活Notch1 / Hes1途径。我们还表明,Notch1和Hes1的表达在Pdacs的50%(33/66)中存在,但不存在于胰腺上皮内肿瘤中。这些发现表明,Notch1活化仅在胰腺癌发生后期显而易见,旨在用包括γ-分泌酶的Notch-信号传导抑制剂治疗应选择性地用于具有证实的Notch1信号传导激活的PDAC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号